未登录

P

Pierre V. Candelaria

university of california

H指数:12

被引数:736

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of an Fc-silent antibody targeting the apical domain of human transferrin receptor 1 in transgenic mouse models of Junín virus infection

靶向人转铁蛋白受体1顶端结构域的Fc沉默抗体在转基因小鼠模型中针对胡宁病毒感染的疗效

Antiviral Research

IF4

2026-04-280

PRE

hu128.1, a humanized antibody targeting transferrin receptor 1, blocks erythroleukemia growth in xenograft mouse models

hu128.1，一种靶向转铁蛋白受体1的人源化抗体，可阻断异种移植小鼠模型中的红白血病生长。

IF7.9

2024-12-120

OA

Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections

NATURE COMMUNICATIONS

IF15.7

2022-01-286

OAAI

Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBVthorn Human Primary B-cells

MOLECULAR CANCER THERAPEUTICS

IF5.5

2021-06-224

OA

Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-03-17156

OAAI

Efficacy of antibodies targeting TfR1 in xenograft mouse models of AIDS-related non-Hodgkin lymphoma

CANCER RESEARCH

IF16.6

2020-08-151

PRE

Targeting transferrin receptor 1 (TfR1) with the ch128.1/IgG1 antibody inhibits Epstein-Barr virus (EBV) driven lymphoproliferative growth and lymphomagenesis in immunosuppressed mice bearing human B cells

CANCER RESEARCH

IF16.6

2020-08-151

PRE

Combination therapy with an antibody specific for transferrin receptor 1 (ch128.1/IgG1) and bortezomib or lenalidomide results in increased survival in an in vivo model of human multiple myeloma

CANCER RESEARCH

IF16.6

2020-08-151

PRE

An IgG1 Version of the Anti-transferrin Receptor 1 Antibody ch128.1 Shows Significant Antitumor Activity Against Different Xenograft Models of Multiple Myeloma: A Brief Communication

JOURNAL OF IMMUNOTHERAPY

IF2.9

2019-10-3011

OAAI

Amino acid residues involved in the heparin-binding activity of murine IL-12 in the context of an antibody-cytokine fusion protein

IF3.7

2019-08-015

OAAI

An IgG1 version of the anti-TfR1 antibody ch128.1 shows significant antitumor activity against different xenograft models of multiple myeloma

CANCER RESEARCH

IF16.6

2018-07-010

PRE

Efficacy and Mechanism of Antitumor Activity of an Antibody Targeting Transferrin Receptor 1 in Mouse Models of Human Multiple Myeloma

JOURNAL OF IMMUNOLOGY

IF3.4

2018-05-1523

OAAI

Role of macrophages in the antitumor activity of an anti-transferrin receptor 1 antibody ch128.1 in a xenograft model of multiple myeloma

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Novel adjuvant therapy for obesity-related cancers

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2017-02-050

PRE

PEG-LPrA2 is a non-toxic adjuvant for triple negative breast cancer

CANCER RESEARCH

IF16.6

2016-07-150

PRE

Disparity of innate immunity-related gene effects on asthma and allergy on Karelia

先天免疫相关基因对卡累利阿哮喘和过敏的影响差异

PEDIATRIC ALLERGY AND IMMUNOLOGY

IF4.5

2011-07-1324

PREAI

The importance of environment on respiratory genotype/phenotype relationships in the Inuit

IF12

2010-01-059

PREAI

β2-Adrenoceptor polymorphisms and asthma phenotypes:: interactions with passive smoking

EUROPEAN RESPIRATORY JOURNAL

IF21

2007-04-1136

OAAI

Evolution and respiratory genetics

EUROPEAN RESPIRATORY JOURNAL

IF21

2006-11-3025

OAAI

Growth in the presence of salicylate increases fluoroquinolone resistance in Staphylococcus aureus

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

1999-04-0157

OAAI